Limba, John Michael A.
HRN: 01-62-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/01/2024
04/08/2024
IVT
300mg
Q8
Supraclavicular Abscess, Right
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes